Biopharmaceutical Company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | EMPIRE CONSULTING GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| EMPIRE CONSULTING GROUP | 41 | — |
| Issue | Activities |
|---|---|
| Health Issues | 41 |
| Copyright/Patent/Trademark | 3 |
| Taxation/Internal Revenue Code | 1 |